Neuromodulation Virtual Care Technology Provides Safe and Effective Drg/Scs Remote Programming: E-Poster Viewing

ABSTRACT

Introduction: About 20.4% of US adults suffer from chronic pain and need consistent management plans which were disrupted in 2020 with the COVID-19 pandemic.1,2,3 Patients who use programmable neuromodulation devices to treat chronic pain typically require follow-up visits to address changes in symptoms. An FDA-approved teleprogramming platform enables real-time remote programming via mobile devices for movement disorder and chronic pain patients who use neuromodulation devices. The platform eases the burden travel imposed on many patients, allowing physicians to quickly resolve patient symptoms. The Remote Optimization, Adjustment, and Measurement for Chronic Pain Therapy (ROAM-CPT) study is a post-market, prospective, non-randomized, multi-center investigation to determine that the telehealth system meets patients' therapeutic needs safely and effectively. Materials / Methods: 62 consented subjects across 4 sites, with an implanted neuromodulation device, participating in the REALITY study (NCT03876054) were enrolled in ROAM-CPT and were provided access to the telehealth software. A questionnaire designed for both patient and physician was available after each remote session. The primary success rate was determined by the ability to establish an audio-video connection, complete remote programming or device check, and provide patient clinical care similar to an in-patient session. Additionally, the physicians' and patients' preferences, satisfaction, and reduction in the burden of care compared to in-person sessions were determined. Result(s) 15 patients initiated and completed an audio-video session. All physicians' confirmed services are akin to in-person sessions. During the study, 53.3% of the sessions were complex programming (change in three or more parameters), 26.7% simple programming (change in 1-2 parameter), and 20.0% device interrogation. Overall, all surveyed providers preferred remote care and 93.3% (14/15) of subjects did not require additional clinical care services. Of the 15 subjects across 4 sites, all but 1 reported rapid resolution (reduction in pain), preferred remote care to in-patient, and would recommend a remote session. Patients also reported getting faster appointment time as well as saving travel time and resources typically spent towards an in-person session. Discussion(s) The remote neuromodulation technology provides secure audio-video chat connectivity, programming changes such as amplitude, systems check, and session reports. Physicians easily provide patients care using this platform while patients' therapeutic needs were quickly resolved from the comfort of their homes using their mobile devices. Conclusion(s) Teleprogramming provides real-time programming capabilities and optimizes therapy for patients with neurostimulation devices. Learning Objectives: 1. Teleprogramming provides real-time, safe programming that equals an in-person session. No safety concerns were recorded for all 15 session 2. Virtual clinic affords clinicians the ability to provide quick patient care, does not increase the need for additional follow-up. All 15 participating patients reported resolved therapy needs. 14/15 did not require additional follow-up. 3. Physicians and patients both prefer Virtual clinic 4/4 surveyed physicians and 14/15 surveyed patients preferred virtual clinic. Keywords Teleprogramming, Neuromodulation, Neurosphere, Virtual clinic, Remote programming, Telehealth Copyright © 2022